Tenofovir disoproxil fumarate
NDC 69097-533, Tenofovir disoproxil fumarate, tablet, from Cipla USA Inc..
- Product NDC
- 69097-533
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078800
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TENOFOVIR DISOPROXIL FUMARATE300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-533-02 | 69097053302 | 30 TABLET in 1 BOTTLE (69097-533-02) |
| 69097-533-15 | 69097053315 | 1000 TABLET in 1 BOTTLE (69097-533-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/de27413a-6579-4586-80dc-39c712652952NADAC price for package 69097053302
GET /v1/drugs/nadac/69097053302
Use it
Look up 69097-533 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.